News Daily News For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis Yael L. Maxwell August 14, 2025
News Daily News Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity L.A. McKeown August 07, 2025
News Daily News Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol Michael O'Riordan August 06, 2025
News Conference News SCCT 2025 Leaders in Cardiac CT Look Back on 20 Years of Growth Despite Challenges Yael L. Maxwell July 25, 2025
News Daily News Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data L.A. McKeown July 24, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Conference News SCCT 2025 AI-Based Coronary Plaque Analysis Can Inform Management Beyond CCTA: DECIDE Registry Yael L. Maxwell July 21, 2025
News Conference News SCCT 2025 Adding Coronary CT Angiography to Annual Firefighter Physicals Could Save Lives Yael L. Maxwell July 18, 2025
News Daily News Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050 Todd Neale July 16, 2025
News Daily News FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF Caitlin E. Cox July 14, 2025
News Daily News Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis Michael O'Riordan July 03, 2025
News Daily News Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC Michael O'Riordan June 25, 2025
News Daily News Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years Yael L. Maxwell June 09, 2025
News Daily News Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says Todd Neale June 06, 2025
News Daily News Liberal Transfusion Strategy for Acute MI and Anemia Doesn’t Impact QoL Michael O'Riordan June 06, 2025
News Daily News Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI L.A. McKeown June 05, 2025
News Daily News Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION Michael O'Riordan June 04, 2025